2014
$215M
from 9 investors over 9 rounds
Atea Pharmaceuticals, Inc raised $215M on May 20, 2020
Investors: Omega Funds, Sectoral Asset Management, T. Rowe Price, Morningside Venture Capital 晨兴资本, Perceptive Advisors, RA Capital Management, L.P., Redmile Group and Solasta Ventures
Atea Pharmaceuticals, Inc raised $20M on September 17, 2014
Investors: RMI Partners